Filovirus vaccines: what challenges are left?

被引：4
|
作者：
Bukreyev, Alexander [1 ]
Collins, Peter L. [1 ]
机构：
[1] NIAID, RNA Viruses Sect, Infect Dis Lab, NIH, Bethesda, MD 20892 USA
来源：
EXPERT REVIEW OF VACCINES | 2010年 / 9卷 / 01期
关键词：
PROTECTS NONHUMAN-PRIMATES; STOMATITIS-VIRUS VECTORS; EBOLA HEMORRHAGIC-FEVER; MARBURG VIRUS; POSTEXPOSURE PROTECTION; RHESUS-MONKEYS; GUINEA-PIGS; INFECTION; IMMUNITY; TRANSMISSION;
D O I：
10.1586/ERV.09.150
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：5 / 8
页数：4
相关论文
共 50 条
  • [1] Filovirus vaccines
    Bradfute, Steven B.
    Dye, John M.
    Bavari, Sina
    HUMAN VACCINES, 2011, 7 (06): : 701 - 711
  • [2] Potential Vaccines and Post-Exposure Treatments for Filovirus Infections
    Friedrich, Brian M.
    Trefry, John C.
    Biggins, Julia E.
    Hensley, Lisa E.
    Honko, Anna N.
    Smith, Darci R.
    Olinger, Gene G.
    VIRUSES-BASEL, 2012, 4 (09): : 1619 - 1650
  • [3] Filovirus vaccines as a response paradigm for emerging infectious diseases
    Marzi, Andrea
    Feldmann, Heinz
    NPJ VACCINES, 2024, 9 (01)
  • [4] Codon-optimized filovirus DNA vaccines delivered by intramuscular electroporation protect cynomolgus macaques from lethal Ebola and Marburg virus challenges
    Grant-Klein, Rebecca J.
    Altamura, Louis A.
    Badger, Catherine V.
    Bounds, Callie E.
    Van Deusen, Nicole M.
    Kwilas, Steven A.
    Vu, Hong A.
    Warfield, Kelly L.
    Hooper, Jay W.
    Hannaman, Drew
    Dupuy, Lesley C.
    Schmaljohn, Connie S.
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2015, 11 (08) : 1991 - 2004
  • [5] Challenges, Progress, and Opportunities: Proceedings of the Filovirus Medical Countermeasures Workshop
    Hirschberg, Rona
    Ward, Lucy A.
    Kilgore, Nicole
    Kurnat, Rebecca
    Schiltz, Helen
    Albrecht, Mark T.
    Christopher, George W.
    Nuzum, Ed
    VIRUSES-BASEL, 2014, 6 (07): : 2673 - 2697
  • [6] Ebola and filovirus disease: Challenges and prospects for 2030
    Malvy, Denis
    BULLETIN DE L ACADEMIE NATIONALE DE MEDECINE, 2023, 207 (06): : 787 - 805
  • [7] Recombinant Protein Filovirus Vaccines Protect Cynomolgus Macaques From Ebola, Sudan, and Marburg Viruses
    Lehrer, Axel T.
    Chuang, Eleanore
    Namekar, Madhuri
    Williams, Caitlin A.
    Wong, Teri Ann S.
    Lieberman, Michael M.
    Granados, Alex
    Misamore, John
    Yalley-Ogunro, Jake
    Andersen, Hanne
    Geisbert, Joan B.
    Agans, Krystle N.
    Cross, Robert W.
    Geisbert, Thomas W.
    FRONTIERS IN IMMUNOLOGY, 2021, 12
  • [8] Preexisting Immunity Does Not Prevent Efficacy of Vesicular Stomatitis Virus-Based Filovirus Vaccines in Nonhuman Primates
    Marzi, Andrea
    Feldmann, Friederike
    O'Donnell, Kyle L.
    Hanley, Patrick W.
    Messaoudi, Ilhem
    Feldmann, Heinz
    JOURNAL OF INFECTIOUS DISEASES, 2023, 228 : S671 - S676
  • [9] Approaches to demonstrating the effectiveness of filovirus vaccines: Lessons from Ebola and COVID-19
    Gruber, Marion F.
    Rubin, Steven
    Krause, Philip R.
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [10] A review of Phase I trials of Ebola virus vaccines: what can we learn from the race to develop novel vaccines?
    Lambe, Teresa
    Bowyer, Georgina
    Ewer, Katie J.
    PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES, 2017, 372 (1721)
12345